We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · July 23, 2019

Vinorelbine/Lapatinib Is Safe and Effective in Patients With HER2+ Metastatic Breast Cancer

Anticancer Research


Additional Info

Disclosure statements are available on the authors' profiles:

Anticancer Research
A Systematic Review and Meta-Analysis of the Combination of Vinorelbine and Lapatinib in Patients With Her2-Positive Metastatic Breast Cancer
Anticancer Res. 2019 Jul 01;39(7)3295-3301, A Stravodimou, IA Voutsadakis

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading